Searched for
OXFORD VACCINE INDIA
Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...- Moderna and other groups get $60 million to develop Ebola vaccineCEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...
- What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
- Ebola at the gates: Why India must not let its guard downIndia is enhancing its surveillance protocols following an Ebola outbreak in the Democratic Republic of Congo and Uganda. One of two suspec...
- Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 monthsA new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. ...
- Oxford University strikes new malaria vaccine pact with Serum Institute of IndiaOxford University and Serum Institute of India are collaborating on a new malaria vaccine, R78C. This partnership aims to create a more eff...
- AZ booster raises antibody levels against Omicron, says firmIt said that the increased response was observed in people who were previously vaccinated with either Vaxzevria or an mRNA vaccine, adding ...
- Oxford University to get Poonawala vaccine research facility; to get GBP 50 million fundingSerum Life Sciences is wholly-owned by the Poonawalla family, owners of the Adar Poonawalla-led Serum Institute of India, and the proposed ...
- Sri Lanka temporarily suspends COVID-19 jabs due to delay in securing vaccines from SII: MinisterSri Lanka launched its inoculation programme in late January when India gifted 500,000 doses of Oxford-AstraZeneca. Till Thursday 913,219 p...
- Single dose of Pfizer and Astrazeneca Covid vaccines highly effective: StudiesIsraeli studies have found the Pfizer vaccine to be 95 percent effective one week after a second jab, while the Lancet report focused on mo...
- India to start coronavirus vaccine exports as soon as Wednesday, starting with BhutanTwo million doses of the vaccine, developed by AstraZeneca and Oxford University and manufactured by Serum Institute of India (SII), will a...
- AstraZeneca-Oxford vaccine still under review: UK drug regulatorThe subject expert committee in India is awaiting a nod from the UK's regulator to sign off on the marketing authorisation for SII to deliv...
- AstraZeneca-Oxford vaccine safe, Indian trials progressing smoothly: Serum InstituteVaccine major Serum Institute of India on Thursday said the Covid-19 vaccine developed by AstraZeneca and Oxford University is safe and eff...
- Covid-19: Govt may get Oxford shots in Jan-Feb, at 50% of MRPIndia is likely to get the first lot of anti-Covid shots in late January-early February. This will be possible as India plans to give Serum...
- India health authorities betting on AstraZeneca, Bharat Biotech vaccines“India will have to focus on the indigenous vaccines and the AstraZeneca-Oxford vaccine. These vaccines are being tested in the India popul...
- Will govt have Rs 80,000 cr for distribution of vaccine, asks Serum Institute CEOThis is the next "challenge" we need to tackle, he said, also tagging the prime minister's office. "I ask this question because we need to ...
- Serum Institute of India to start phase II trials of Oxford vaccine this weekPhase I human trials were completed in the UK. In India, the volunteers will be administered two doses of the potential vaccine. Thereafter...
- Serum Institute of India to apply for local trials on Oxford's vaccine by AugustSII, the largest vaccine manufacturer in the world, has tied up with AstraZeneca to manufacture the Covid-19 vaccine. SII’s vaccine candida...
- Government lab starts testing Oxford’s vaccine candidate to determine its sterilityThe Central Drugs Laboratory in Kasauli, Himachal Pradesh, is testing the first batch of the vaccine candidate to determine its sterility —...
- Serum Institute to start manufacturing Oxford University's COVID vaccine in 3 weeks; launch by October if trials succeed"Our team has been working closely with Dr Hill from Oxford University, and we are expecting to initiate production of the vaccine in 2-3 w...
Load More
